Catalyst Wire Dossier Catalyst Wire Dossier

Antiplatelet agent

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Antiplatelet agent, covering 2024-06-10 to 2024-06-10. Get the full timeline:

Most recent: Clinical Trial Update: Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease [Phase 4]

See pricing